SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : HTDS - Hard To Treat Diseases
HTDS 0.00002000.0%Nov 28 9:30 AM EST

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
From: Lateott7/7/2005 5:44:15 PM
   of 271
 
DECISION RENDERED: Hard to Treat Diseases, Inc. v. Shinn et al., 04-800010. The court has entered a memorandum opinion with findings of fact and conclusions of law holding that (1) the parties' share exchange agreement did close, (2) a Hawaiian corporation known as Shinn Capital owns the right to market a product called Tubercin, and (3) a Florida corporation known as Hard to Treat Diseases, Inc. (Florida) owns 100% of the assets of two Oklahoma corporations: Hard to Treat Diseases, Inc. (Oklahoma) and T-19, Inc. and, therefore, the Florida corporation is entitled to a money judgment against Dr. Ronald Shinn in the sum of $201,620.01. Copies of the court's opinion may be obtained from the clerk of court.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext